USPTO serial 86656969
QIAGEN GENEREAD SMCOUNTER
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- RINKER, ANTHONY MICHAEL
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with QIAGEN GENEREAD SMCOUNTER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for scientific or research use, not for human medicine and veterinary medicine purposes; reagents and solvents for scientific or research use not for human medical and veterinary purposes, namely, for sample preparation, modification and manipulation of cells as well as for the performance of labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; kits consisting primarily of nucleic acid compounds, protein assays and chemical reagents for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and proteins from biological material, all for scientific or research use, other than human medicine and veterinary medicine purposes | ACTIVE | — |
| 005 | Diagnostic preparations for medical and veterinary use; products for human medicine and veterinary medicine purposes, namely, diagnostic preparations, in particular for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; chemical biochemical and biotechnological products all for human medicine and veterinary medicine purposes, namely, reagents and solvents, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; kits consisting primarily of nucleic acid compounds, protein assays and chemical reagents for human medicine or veterinary medicine diagnostic purposes, namely, for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and proteins from biological material | ACTIVE | — |
| 009 | Scientific apparatuses, instruments and equipment, namely, optical apparatuses and instruments for laboratory purposes, namely, microscopes, calculating machines, electrical and electronic apparatuses and instruments, namely, sequencers and sequencing machines for research and analysis purposes in the field of molecular biology; laboratory equipment, measuring apparatuses and instruments, namely, robot manipulators, laboratory consumable dispensers, laboratory sample conditioners, namely, incubators, stirrers, mixers, dispensers, aspirators; laboratory and measuring apparatuses and instruments, namely, filter systems for laboratory purposes, fluid sample ultrafiltration devices and apparatuses, fluid sample ultrafiltration membranes, chromatography apparatuses and instruments, ion exchanger apparatuses and instruments, laboratory nucleic acid polymer oligonucleotide concentrator devices; scientific apparatuses and instruments being laboratory equipment and single-use laboratory articles, namely, laboratory apparatuses for the processing of fluid samples, namely, apparatuses for dosing, transferring, mixing, tempering, concentrating, homogenizing and filtering of sample liquids and reagents for medical and veterinary medical diagnostic purposes, in particular for sample preparation, modification and manipulation of cells and for labeling, separation, isolation, reproduction and the purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and proteins from biological material | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and development in the fields of medical diagnostic testing, cancer treatment and diagnosis, treatment and diagnosis of viral and bacterial mediated diseases, treatment and diagnosis of diseases of the blood, treatment and diagnosis of diseases of the skin, treatment and diagnosis of diseases of the brain, treatment and diagnosis of diseases of the heart, treatment and diagnosis of diseases of the liver, treatment and diagnosis of diseases of the lungs; as well as design services, namely, work on and evaluation of chemical syntheses, namely, the synthesis of oligonucleotides, polynucleotides and proteins | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by QIAGEN Sciences, LLC
- Other trademarks owned by QIAGEN Sciences, LLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named QIAGEN GENEREAD SMCOUNTER
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 26, 2018 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 26, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 13, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 9, 2017 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 9, 2017 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 9, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 4, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 2, 2016 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 2, 2016 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 2, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 26, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 31, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 31, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 11, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 21, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 24, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 23, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 24, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 17, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 12, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 12, 2015 | NWAP | NEW APPLICATION ENTERED | — |